James Wynn urgently reduces BTC long position to 3,375 units, liquidation price lowered to $105,960

Pitney Bowes recently announced strong preliminary results for the first quarter of 2026, surpassing market expectations.

Cogent Biosciences announced that its PEAK Phase III clinical trial for gastrointestinal stromal tumors (GIST) has achieved positive results, and the study has been selected for the oral presentation session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

DeFi Dev announced participation in the Ministry of Finance accelerator program and will make a strategic equity investment in Allied Architects.

GE Aerospace's Chief Financial Officer stated that the company expects its service business to achieve high double-digit growth in the second quarter, surpassing the annual financial guidance.